Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modern treatment of Hodgkin lymphoma.
Bartlett NL. Bartlett NL. Curr Opin Hematol. 2008 Jul;15(4):408-14. doi: 10.1097/MOH.0b013e328302c9d8. Curr Opin Hematol. 2008. PMID: 18536581 Review.
New therapies in Hodgkin's lymphoma.
Bartlett N. Bartlett N. Clin Adv Hematol Oncol. 2004 Feb;2(2):80, 83. Clin Adv Hematol Oncol. 2004. PMID: 16163165 No abstract available.
Management of advanced stage Hodgkin's lymphoma.
Bartlett NL, Smukler AJ. Bartlett NL, et al. Cancer Treat Res. 2006;131:333-52. doi: 10.1007/978-0-387-29346-2_11. Cancer Treat Res. 2006. PMID: 16704175 Review. No abstract available.
Therapy of relapsed Hodgkin lymphoma.
Cashen AF, Bartlett NL. Cashen AF, et al. Among authors: bartlett nl. Blood Rev. 2007 Sep;21(5):233-43. doi: 10.1016/j.blre.2007.06.001. Epub 2007 Aug 1. Blood Rev. 2007. PMID: 17683834 Review.
Salvage regimens for Hodgkin lymphoma.
Cashen AF, Bartlett NL. Cashen AF, et al. Among authors: bartlett nl. Clin Adv Hematol Oncol. 2008 Jul;6(7):517-24. Clin Adv Hematol Oncol. 2008. PMID: 18654119 Review.
Anti-CD30 Antibodies for Hodgkin lymphoma.
Foyil KV, Bartlett NL. Foyil KV, et al. Among authors: bartlett nl. Curr Hematol Malig Rep. 2010 Jul;5(3):140-7. doi: 10.1007/s11899-010-0053-y. Curr Hematol Malig Rep. 2010. PMID: 20446121 Review.
The present: optimizing therapy--too much or too little?
Bartlett NL. Bartlett NL. Hematology Am Soc Hematol Educ Program. 2010;2010:108-14. doi: 10.1182/asheducation-2010.1.108. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239779 Review.
292 results